Vaxess Technologies
company
About
Vaxess Technologies engages in developing biomedical innovations with a focus on improving access to vaccines.
- 1 - 10
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $1.50M
- Industries
- Biotechnology,Health Care,Medical
- Founded date
- Dec 18, 2011
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Vaxess is commercializing a proprietary technology that uses a silk-derived protein to stabilize vaccines so they can be stored and shipped without refrigeration and a novel sustained release microneedle for improved vaccine delivery. Vaxess strives to not only lower the cost of vaccine distribution, but also increase access to life-saving products for people around the world.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
8
$8.16M
Vaxess Technologies has raised a total of
$8.16M
in funding over 2 rounds. Their latest funding was raised on
Sep 1, 2020 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 1, 2020 | Grant | $256K | 1 |
National Science Foundation
|
— | Detail |
| Oct 9, 2018 | Grant | $650K | 1 |
National Science Foundation
|
— | Detail |
| Dec 14, 2017 | Grant | $1.50M | 1 | — | — | Detail |
| Sep 20, 2016 | Grant | $1.40M | 1 |
National Science Foundation
|
— | Detail |
| Apr 6, 2015 | Grant | $220K | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
4
3
Vaxess Technologies is funded by 3 investors.
National Science Foundation
and Norwich Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Science Foundation
|
Yes | Grant |
Norwich Ventures
|
Yes | Series A |
National Institutes of Health
|
— | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
